Posts

MiraKind Ask me Anything

Why you should get your KRAS-variant results

Dear study participants, I wanted to share an experience that I had today. I had a wonderful conversation with a woman who participated in the first MiraKind study.  While I always enjoy…

Read More ➝
Samples in a lab

The truth about GWAS and the KRAS-variant

Although much of the world has accepted that GWAS studies, which use an outdated technology looking at large amounts of data, have failed to find any functional mutations, this approach has twice…

Read More ➝

Using My Illness to Change the Future

A Guest Post by Nancy Bower Kantola Chavez: “It’s definitely cancer” is what I heard on the second day of my summer vacation in July 1995. I was 34 years old and…

Read More ➝
Dr. Joanne Weidhass, Discover Magazine

How does breast cancer treatment impact second breast cancer risk?

We are embarking on a study to explore how breast cancer management strategies (e.g., chemotherapy, surgery, hormones) that are used to treat breast cancer, impact breast cancer risk for women with the KRAS-variant.

Read More ➝
curve-up2
arrow up to top